Changchun High-Tech Industry (Group) Co., Ltd. (SHE:000661)
99.83
+0.80 (0.81%)
Mar 28, 2025, 2:45 PM CST
SHE:000661 Revenue
Changchun High-Tech Industry (Group) had revenue of 3.75B CNY in the quarter ending September 30, 2024, a decrease of -16.94%. This brings the company's revenue in the last twelve months to 14.27B, up 4.46% year-over-year. In the year 2023, Changchun High-Tech Industry (Group) had annual revenue of 14.57B with 15.35% growth.
Revenue (ttm)
14.27B
Revenue Growth
+4.46%
P/S Ratio
2.83
Revenue / Employee
1.58M
Employees
9,029
Market Cap
40.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.57B | 1.94B | 15.35% |
Jan 1, 2023 | 12.63B | 1.88B | 17.50% |
Jan 1, 2022 | 10.75B | 2.17B | 25.30% |
Dec 31, 2020 | 8.58B | 1.20B | 16.31% |
Dec 31, 2019 | 7.37B | 2.00B | 37.19% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |